Perfusion Abnormalities in Hypertrophic Cardiomyopathy (NCT06599229)

🧪 Interventions in This Study

• myocardial contrast echo (DIAGNOSTIC_TEST)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Virginia — Charlottesville, Virginia

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Hypertrophic Cardiomyopathy (HCM)

• COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) — Durham, North Carolina
• Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy — Kansas City, Missouri
• Large Language Models To Improve the Quality of Care of Cardiology Patients — Palo Alto, California
• HCMR Re-Imaging Study — Evanston, Illinois

Explore by condition: All Hypertrophic Cardiomyopathy (HCM) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.